F-230

N/A

Report date: 2025/06/18 10:44:01
NME

Base Information

Drug NameF-230
Drug Alias NameF230F-230
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor antagonists
TargetsEndothelin receptor
Therapy Area/IndicationsPulmonary Arterial HypertensionHypertension, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesEisai Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGyre Pharmaceuticals LtdBeijing Continent Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial HypertensionHypertension, Pulmonary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A